ea0085oc10.4 | Oral Communications 10 | BSPED2022
Marie Larkin Anne
, Morrissey Rose
, Kaur Gurpreet
, Morgan Kate
, Rita Batista Ana
Background: For chronic non–life-threatening conditions such as growth hormone deficiency, adherence to treatment can be difficult to maintain at a high level especially when the benefits are not immediately apparent.1 Here, we briefly explore some of the components within an e-health ecosystem that aims at personalizing treatment and improving adherence among patients receiving recombinant human growth hormone (r hGH; somatropin, Merck Healthcare KGaA, Darmsta...